Naoyuki Matsuda Selected Research

Post-Cardiac Arrest Syndrome

11/2021	The rCAST score is useful for estimating the neurological prognosis in pediatric patients with post-cardiac arrest syndrome before ICU admission: External validation study using a nationwide prospective registry.
1/2021	Outcome Related to Level of Targeted Temperature Management in Postcardiac Arrest Syndrome of Low, Moderate, and High Severities: A Nationwide Multicenter Prospective Registry.
1/2019	External validation of a risk classification at the emergency department of post-cardiac arrest syndrome patients undergoing targeted temperature management.
1/2018	Differential effect of mild therapeutic hypothermia depending on the findings of hypoxic encephalopathy on early CT images in patients with post-cardiac arrest syndrome.
5/2017	A novel scoring system for predicting the neurologic prognosis prior to the initiation of induced hypothermia in cases of post-cardiac arrest syndrome: the CAST score.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Naoyuki Matsuda Research Topics

Disease

40	Sepsis (Septicemia) 01/2022 - 08/2002
15	Septic Shock (Toxic Shock Syndrome) 08/2021 - 08/2002
13	Inflammation (Inflammations) 02/2020 - 12/2002
7	Acute Lung Injury 12/2020 - 11/2004
6	Tachycardia (Tachyarrhythmias) 11/2020 - 12/2002
6	Multiple Organ Failure (MODS) 01/2016 - 08/2002
5	Post-Cardiac Arrest Syndrome 11/2021 - 05/2017
4	Heart Arrest (Cardiac Arrest) 01/2021 - 12/2016
4	Hypotension (Low Blood Pressure) 01/2020 - 12/2002
4	Shock 01/2019 - 10/2003
4	Endotoxemia 08/2006 - 12/2002
4	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2005 - 08/2002
3	Respiratory Insufficiency (Respiratory Failure) 01/2021 - 05/2020
3	Cardiac Arrhythmias (Arrythmia) 01/2021 - 01/2020
3	Heart Failure 08/2018 - 01/2003
3	Critical Illness (Critically Ill) 01/2018 - 10/2003
3	Lung Injury 12/2016 - 03/2008
3	Disseminated Intravascular Coagulation 01/2005 - 01/2003
2	Pulmonary Edema 01/2022 - 01/2021
2	Necrosis 10/2021 - 01/2019
2	Neoplasms (Cancer) 10/2021 - 01/2019
2	Delirium 02/2020 - 01/2018
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2018 - 01/2003
2	Low Cardiac Output 01/2018 - 06/2017
2	Pancreatitis 01/2017 - 08/2006
2	Infections 12/2016 - 02/2016
2	Wounds and Injuries (Trauma) 02/2016 - 12/2002
2	Hyperglycemia 10/2009 - 02/2008
1	Obesity 10/2021
1	Type 2 Diabetes Mellitus (MODY) 10/2021
1	Lymphoma (Lymphomas) 01/2021
1	Left Ventricular Dysfunction 01/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021
1	Out-of-Hospital Cardiac Arrest 01/2021
1	Pulmonary Embolism 01/2021
1	Edema (Dropsy) 12/2020
1	COVID-19 12/2020
1	Pneumonia (Pneumonitis) 12/2020
1	Interstitial Lung Diseases (Interstitial Lung Disease) 05/2020
1	Sinus Tachycardia 01/2020
1	Atrial Flutter (Flutter, Atrial) 01/2020
1	Atrial Fibrillation 01/2020
1	Frailty 12/2019

Drug/Important Bio-Agent (IBA)

7	Histamine (Histamine Dihydrochloride)FDA Link 01/2022 - 12/2002
7	NF-kappa B (NF-kB)IBA 01/2019 - 12/2004
6	CytokinesIBA 10/2021 - 01/2014
6	OligodeoxyribonucleotidesIBA 01/2020 - 12/2004
5	Dacarbazine (DIC)FDA LinkGeneric 01/2005 - 08/2002
4	Transcription Factors (Transcription Factor)IBA 01/2022 - 04/2005
4	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 08/2018 - 03/2008
4	LipopolysaccharidesIBA 11/2012 - 12/2002
4	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2005 - 08/2002
3	Oxygen (Dioxygen)IBA 01/2021 - 05/2020
3	landiololIBA 11/2020 - 01/2014
3	NF-kappaB decoyIBA 03/2010 - 12/2004
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 12/2020
2	Nucleic AcidsIBA 01/2022 - 08/2018
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022 - 01/2018
2	Insulin (Novolin)FDA Link 10/2021 - 10/2009
2	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 10/2009
2	CatecholaminesIBA 02/2020 - 01/2020
2	MelatoninIBA 02/2020 - 01/2018
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 02/2020 - 01/2019
2	MicroRNAs (MicroRNA)IBA 01/2019 - 02/2015
2	Dobutamine FDA LinkGeneric 01/2018 - 06/2017
2	Milrinone (Primacor)FDA LinkGeneric 01/2018 - 06/2017
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2018 - 04/2005
2	Simendan (Levosimendan)IBA 01/2018 - 11/2015
2	Messenger RNA (mRNA)IBA 01/2018 - 12/2008
2	Pharmaceutical PreparationsIBA 01/2016 - 10/2012
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 02/2011 - 12/2008
2	Peptide Hydrolases (Proteases)FDA Link 01/2010 - 08/2006
2	Caspase 3 (Caspase-3)IBA 01/2010 - 10/2007
2	Proteinase-Activated ReceptorsIBA 08/2006 - 11/2004
2	SelectinsIBA 01/2005 - 12/2002
2	ThrombomodulinIBA 01/2005 - 12/2002
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2005 - 12/2002
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2005 - 12/2002
2	EndotoxinsIBA 11/2004 - 10/2003
2	lipoprotein-associated coagulation inhibitor (TFPI)IBA 01/2003 - 08/2002
2	Thromboplastin (Tissue Factor)IBA 01/2003 - 08/2002
1	Thromboxane A2 (A2, Thromboxane)IBA 01/2022
1	InterleukinsIBA 10/2021
1	Interleukin-6 (Interleukin 6)IBA 10/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2021
1	Bevacizumab (Avastin)FDA Link 12/2020
1	Monoclonal AntibodiesIBA 12/2020
1	Vasopressins (Vasopressin)IBA 12/2019

Therapy/Procedure

17	Punctures 12/2020 - 04/2005
17	Ligation 12/2020 - 01/2003
14	Therapeutics 11/2020 - 12/2006
7	Induced Hypothermia 11/2021 - 12/2016
7	Critical Care (Surgical Intensive Care) 08/2021 - 01/2014
3	Extracorporeal Membrane Oxygenation 01/2021 - 08/2018
2	Resuscitation 01/2020 - 08/2011
2	Intravenous Injections 01/2019 - 12/2004
2	Anesthesia 10/2012 - 08/2012
2	Hemodiafiltration 11/2003 - 10/2003
1	Artificial Respiration (Mechanical Ventilation) 12/2020
1	Cannula 05/2020